1. Home
  2. PLAB vs NVAX Comparison

PLAB vs NVAX Comparison

Compare PLAB & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLAB
  • NVAX
  • Stock Information
  • Founded
  • PLAB 1969
  • NVAX 1987
  • Country
  • PLAB United States
  • NVAX United States
  • Employees
  • PLAB N/A
  • NVAX N/A
  • Industry
  • PLAB Semiconductors
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PLAB Technology
  • NVAX Health Care
  • Exchange
  • PLAB Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • PLAB 1.2B
  • NVAX 1.3B
  • IPO Year
  • PLAB 1987
  • NVAX 1995
  • Fundamental
  • Price
  • PLAB $22.81
  • NVAX $8.08
  • Analyst Decision
  • PLAB Strong Buy
  • NVAX Buy
  • Analyst Count
  • PLAB 2
  • NVAX 7
  • Target Price
  • PLAB $31.00
  • NVAX $14.29
  • AVG Volume (30 Days)
  • PLAB 705.9K
  • NVAX 6.9M
  • Earning Date
  • PLAB 08-27-2025
  • NVAX 11-11-2025
  • Dividend Yield
  • PLAB N/A
  • NVAX N/A
  • EPS Growth
  • PLAB N/A
  • NVAX N/A
  • EPS
  • PLAB 1.77
  • NVAX 2.54
  • Revenue
  • PLAB $856,152,000.00
  • NVAX $1,078,718,000.00
  • Revenue This Year
  • PLAB N/A
  • NVAX $61.69
  • Revenue Next Year
  • PLAB $5.06
  • NVAX N/A
  • P/E Ratio
  • PLAB $12.85
  • NVAX $3.18
  • Revenue Growth
  • PLAB N/A
  • NVAX 9.22
  • 52 Week Low
  • PLAB $16.46
  • NVAX $5.01
  • 52 Week High
  • PLAB $31.60
  • NVAX $15.22
  • Technical
  • Relative Strength Index (RSI)
  • PLAB 58.45
  • NVAX 53.19
  • Support Level
  • PLAB $21.86
  • NVAX $7.83
  • Resistance Level
  • PLAB $22.87
  • NVAX $8.31
  • Average True Range (ATR)
  • PLAB 0.77
  • NVAX 0.34
  • MACD
  • PLAB -0.05
  • NVAX 0.01
  • Stochastic Oscillator
  • PLAB 38.81
  • NVAX 78.70

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz or glass plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue world-wide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: